cDNA macroarray for analysis of gene expression profiles in prostate cancer. 2006

Wei-de Zhong, and Hui-chan He, and Xue-cheng Bi, and Ru-biao Ou, and Shao-ai Jiang, and Liang-shi Liu
Department of Urology, Guangzhou First Municipal People's Hospital, Guangzhou Medical College, Guangzhou 510180, China. wdezhong@21cn.com

BACKGROUND Early diagnosis and timely treatment are important for improving therapeutic efficiency of prostate cancer. DNA array is a new bio-technology for disease diagnosis. This study was conducted to diagnose prostate cancer with cDNA macroarray and analysis gene expression profiles of some selective genes in prostate cancer. METHODS Total RNA was isolated from patients with prostate cancer and from normal people, and poly (A) RNA was further purified. Then it was analyzed for differentially expressed genes in prostate cancer and normal prostate by cDNA macroarray system. RESULTS There were different expressions in the nine prostate-associated specific genes in prostate cancer as compared with normal prostate, in which, 7 were significantly upregulated and 2 were down-regulated. CONCLUSIONS As a diagnostic approach at molecular level, the cDNA macroarray is an effectively diagnostic method for prostate cancer.

UI MeSH Term Description Entries
D008297 Male Males
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016147 Genes, Tumor Suppressor Genes that inhibit expression of the tumorigenic phenotype. They are normally involved in holding cellular growth in check. When tumor suppressor genes are inactivated or lost, a barrier to normal proliferation is removed and unregulated growth is possible. Antioncogenes,Cancer Suppressor Genes,Emerogenes,Genes, Cancer Suppressor,Genes, Growth Suppressor,Genes, Metastasis Suppressor,Growth Suppressor Genes,Metastasis Suppressor Genes,Tumor Suppressor Genes,Anti-Oncogenes,Genes, Onco-Suppressor,Oncogenes, Recessive,Tumor Suppressing Genes,Anti Oncogenes,Anti-Oncogene,Antioncogene,Cancer Suppressor Gene,Emerogene,Gene, Cancer Suppressor,Gene, Growth Suppressor,Gene, Metastasis Suppressor,Gene, Onco-Suppressor,Gene, Tumor Suppressing,Gene, Tumor Suppressor,Genes, Onco Suppressor,Genes, Tumor Suppressing,Growth Suppressor Gene,Metastasis Suppressor Gene,Onco-Suppressor Gene,Onco-Suppressor Genes,Oncogene, Recessive,Recessive Oncogene,Recessive Oncogenes,Suppressor Gene, Cancer,Suppressor Gene, Growth,Suppressor Gene, Metastasis,Suppressor Genes, Cancer,Suppressor Genes, Growth,Suppressor Genes, Metastasis,Tumor Suppressing Gene,Tumor Suppressor Gene
D017430 Prostate-Specific Antigen A glycoprotein that is a kallikrein-like serine proteinase and an esterase, produced by epithelial cells of both normal and malignant prostate tissue. It is an important marker for the diagnosis of prostate cancer. Kallikrein hK3,gamma-Seminoprotein,hK3 Kallikrein,Prostate Specific Antigen,Semenogelase,Seminin,Kallikrein, hK3,gamma Seminoprotein
D020411 Oligonucleotide Array Sequence Analysis Hybridization of a nucleic acid sample to a very large set of OLIGONUCLEOTIDE PROBES, which have been attached individually in columns and rows to a solid support, to determine a BASE SEQUENCE, or to detect variations in a gene sequence, GENE EXPRESSION, or for GENE MAPPING. DNA Microarrays,Gene Expression Microarray Analysis,Oligonucleotide Arrays,cDNA Microarrays,DNA Arrays,DNA Chips,DNA Microchips,Gene Chips,Oligodeoxyribonucleotide Array Sequence Analysis,Oligonucleotide Microarrays,Sequence Analysis, Oligonucleotide Array,cDNA Arrays,Array, DNA,Array, Oligonucleotide,Array, cDNA,Arrays, DNA,Arrays, Oligonucleotide,Arrays, cDNA,Chip, DNA,Chip, Gene,Chips, DNA,Chips, Gene,DNA Array,DNA Chip,DNA Microarray,DNA Microchip,Gene Chip,Microarray, DNA,Microarray, Oligonucleotide,Microarray, cDNA,Microarrays, DNA,Microarrays, Oligonucleotide,Microarrays, cDNA,Microchip, DNA,Microchips, DNA,Oligonucleotide Array,Oligonucleotide Microarray,cDNA Array,cDNA Microarray
D020869 Gene Expression Profiling The determination of the pattern of genes expressed at the level of GENETIC TRANSCRIPTION, under specific circumstances or in a specific cell. Gene Expression Analysis,Gene Expression Pattern Analysis,Transcript Expression Analysis,Transcriptome Profiling,Transcriptomics,mRNA Differential Display,Gene Expression Monitoring,Transcriptome Analysis,Analyses, Gene Expression,Analyses, Transcript Expression,Analyses, Transcriptome,Analysis, Gene Expression,Analysis, Transcript Expression,Analysis, Transcriptome,Differential Display, mRNA,Differential Displays, mRNA,Expression Analyses, Gene,Expression Analysis, Gene,Gene Expression Analyses,Gene Expression Monitorings,Gene Expression Profilings,Monitoring, Gene Expression,Monitorings, Gene Expression,Profiling, Gene Expression,Profiling, Transcriptome,Profilings, Gene Expression,Profilings, Transcriptome,Transcript Expression Analyses,Transcriptome Analyses,Transcriptome Profilings,mRNA Differential Displays

Related Publications

Wei-de Zhong, and Hui-chan He, and Xue-cheng Bi, and Ru-biao Ou, and Shao-ai Jiang, and Liang-shi Liu
January 2007, Journal of bioscience and bioengineering,
Wei-de Zhong, and Hui-chan He, and Xue-cheng Bi, and Ru-biao Ou, and Shao-ai Jiang, and Liang-shi Liu
April 2002, FEBS letters,
Wei-de Zhong, and Hui-chan He, and Xue-cheng Bi, and Ru-biao Ou, and Shao-ai Jiang, and Liang-shi Liu
May 2007, Oncology reports,
Wei-de Zhong, and Hui-chan He, and Xue-cheng Bi, and Ru-biao Ou, and Shao-ai Jiang, and Liang-shi Liu
January 2003, Methods in molecular medicine,
Wei-de Zhong, and Hui-chan He, and Xue-cheng Bi, and Ru-biao Ou, and Shao-ai Jiang, and Liang-shi Liu
April 2002, Oncogene,
Wei-de Zhong, and Hui-chan He, and Xue-cheng Bi, and Ru-biao Ou, and Shao-ai Jiang, and Liang-shi Liu
October 2003, Cancer research and treatment,
Wei-de Zhong, and Hui-chan He, and Xue-cheng Bi, and Ru-biao Ou, and Shao-ai Jiang, and Liang-shi Liu
May 2005, Alimentary pharmacology & therapeutics,
Wei-de Zhong, and Hui-chan He, and Xue-cheng Bi, and Ru-biao Ou, and Shao-ai Jiang, and Liang-shi Liu
April 2003, The Journal of nutrition,
Wei-de Zhong, and Hui-chan He, and Xue-cheng Bi, and Ru-biao Ou, and Shao-ai Jiang, and Liang-shi Liu
November 2004, Molecular plant-microbe interactions : MPMI,
Wei-de Zhong, and Hui-chan He, and Xue-cheng Bi, and Ru-biao Ou, and Shao-ai Jiang, and Liang-shi Liu
May 2006, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Copied contents to your clipboard!